Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421807

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421807

Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product ; By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032

PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global joint pain injections market size is expected to reach USD 12.36 billion by 2032, according to a new study by Polaris Market Research. The report "Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, Stem Cell Injections, Others); By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

There is a significant opportunity to expand the indications for joint pain injections. Currently, these injections are used for osteoarthritis and related conditions. However, research and development efforts are exploring new indications, potentially covering a broader range of joint conditions, such as tendinitis, bursitis, and other musculoskeletal disorders.

The development and use of biologic joint pain injections, including platelet-rich plasma (PRP), stem cell therapies, and hyaluronic acid derivatives, present a notable growth opportunity. Biologic injections have regenerative potential and can stimulate tissue repair and healing. Incorporating biologics into the joint pain injection market introduces advanced and holistic treatment options, particularly for patients seeking regenerative solutions for their joint conditions.

Personalized medicine is gaining prominence across various healthcare sectors. Tailoring joint pain injections to individual patients based on their specific joint condition, medical history, and genetic factors significantly enhances treatment outcomes. By customizing the choice of medication, dosage, and treatment plan, healthcare providers optimize the effectiveness of joint pain injections and deliver highly tailored pain management solutions to patients.

The adoption of telemedicine and virtual healthcare consultations has become more widespread in the post-COVID era. Patients are increasingly open to discussing joint pain issues remotely, and healthcare providers are leveraging telemedicine to evaluate, diagnose, and prescribe joint pain injections. This integration offers convenience and reduces the need for in-person visits, which aligns with pandemic-induced changes in patient preferences.

The patient experience has gained significance. Healthcare providers are focusing on creating a patient-centered environment that fosters trust and satisfaction. This approach includes enhanced communication, personalized care plans, and comprehensive support for individuals seeking joint pain injections.

Joint Pain Injections Market Report Highlights

Hyaluronic acid injections emerged as the largest segment on account of greater demand for non-surgical alternatives for pain relief and joint improvement

Knee emerged as the largest segment on account of higher incidence of knee-related conditions, preference towards less invasive treatments, and increased patient awareness

Retail pharmacies held the maximum market revenue share in 2022, mainly due to growing consumer demand, convenience, easy access, and e-commerce integration

North America region dominated the market with a majority share in 2022, owing to an aging population, rising prevalence of joint-related conditions like osteoarthritis, and growing demand for non-surgical treatment options

The global key market players include: Anika Therapeutics, Bioventus, Eli Lilly and Company, Ferring Pharmaceuticals, and Pacira BioSciences, Inc., among others

Polaris Market Research has segmented the Joint Pain Injections market report based on product, joint type, distribution channel, and region:

Joint Pain Injections, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Platelet-Rich Plasma Injections
  • Stem Cell Injections
  • Others

Joint Pain Injections, Joint Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hip
  • Knee
  • Shoulder and Elbow
  • Hand and Wrist
  • Others

Joint Pain Injections, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Joint Pain Injections, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Product Code: PM4129

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Joint Pain Injections Market Insights

  • 4.1. Joint Pain Injections Market - Joint Type Snapshot
  • 4.2. Joint Pain Injections Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Aging population, prevalence of joint disorders, and rise in demand for minimally invasive treatments
      • 4.2.1.2. Advancements in biotechnology and innovative formulations
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulatory approvals and compliance challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Joint Pain Injections Market Joint Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Joint Pain Injections Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Corticosteroid Injections
    • 5.3.1. Global Joint Pain Injections Market, by Corticosteroid Injections, by Region, 2019-2032 (USD Billion)
  • 5.4. Hyaluronic Acid Injections
    • 5.4.1. Global Joint Pain Injections Market, by Hyaluronic Acid Injections, by Region, 2019-2032 (USD Billion)
  • 5.5. Platelet-Rich Plasma Injections
    • 5.5.1. Global Joint Pain Injections Market, by Platelet-Rich Plasma Injections, by Region, 2019-2032 (USD Billion)
  • 5.6. Stem Cell Injections
    • 5.6.1. Global Joint Pain Injections Market, by Stem Cell Injections, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Joint Pain Injections Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Joint Pain Injections Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Retail Pharmacies
    • 6.3.1. Global Joint Pain Injections Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Global Joint Pain Injections Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.5. Online Pharmacies
    • 6.5.1. Global Joint Pain Injections Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

7. Global Joint Pain Injections Market, by Joint Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • 7.3. Hip
    • 7.3.1. Global Joint Pain Injections Market, by Hip, By Region, 2019-2032 (USD Billion)
  • 7.4. Knee
    • 7.4.1. Global Joint Pain Injections Market, by Knee, By Region, 2019-2032 (USD Billion)
  • 7.5. Shoulder and Elbow
    • 7.5.1. Global Joint Pain Injections Market, by Shoulder and Elbow, By Region, 2019-2032 (USD Billion)
  • 7.6. Hand and Wrist
    • 7.6.1. Global Joint Pain Injections Market, by Hand and Wrist, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Joint Pain Injections Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Joint Pain Injections Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Joint Pain Injections Market - North America
    • 8.3.1. North America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Joint Pain Injections Market - U.S.
      • 8.3.4.1. U.S.: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Joint Pain Injections Market - Canada
      • 8.3.5.1. Canada: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Joint Pain Injections Market - Europe
    • 8.4.1. Europe: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Joint Pain Injections Market - UK
      • 8.4.4.1. UK: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Joint Pain Injections Market - France
      • 8.4.5.1. France: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Joint Pain Injections Market - Germany
      • 8.4.6.1. Germany: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Joint Pain Injections Market - Italy
      • 8.4.7.1. Italy: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Joint Pain Injections Market - Spain
      • 8.4.8.1. Spain: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Joint Pain Injections Market - Netherlands
      • 8.4.9.1. Netherlands: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Joint Pain Injections Market - Russia
      • 8.4.10.1. Russia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Joint Pain Injections Market - Asia Pacific
    • 8.5.1. Asia Pacific: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Joint Pain Injections Market - China
      • 8.5.4.1. China: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Joint Pain Injections Market - India
      • 8.5.5.1. India: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Joint Pain Injections Market - Malaysia
      • 8.5.6.1. Malaysia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Joint Pain Injections Market - Japan
      • 8.5.7.1. Japan: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Joint Pain Injections Market - Indonesia
      • 8.5.8.1. Indonesia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Joint Pain Injections Market - South Korea
      • 8.5.9.1. South Korea: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Joint Pain Injections Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Joint Pain Injections Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Joint Pain Injections Market - UAE
      • 8.6.5.1. UAE: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Joint Pain Injections Market - Israel
      • 8.6.6.1. Israel: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Joint Pain Injections Market - South Africa
      • 8.6.7.1. South Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Joint Pain Injections Market - Latin America
    • 8.7.1. Latin America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Joint Pain Injections Market - Mexico
      • 8.7.4.1. Mexico: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Joint Pain Injections Market - Brazil
      • 8.7.5.1. Brazil: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Joint Pain Injections Market - Argentina
      • 8.7.6.1. Argentina: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Alkem Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Anika Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bioventus
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eli Lilly and Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Ferring Pharmaceuticals
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. GlaxoSmithKline (GSK)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pacira BioSciences, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sanofi
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Seikagaku Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceuticals
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zimmer Biomet
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
Product Code: PM4129

List of Tables

  • Table 1 Global Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 3 Global Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 4 Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 11 Canada: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Canada: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 14 Europe: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Europe: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 17 UK: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 UK: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 20 France: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 France: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Germany: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 26 Italy: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Italy: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 29 Spain: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Spain: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 35 Russia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Russia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 41 China: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 44 India: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 50 Japan: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 65 UAE: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 UAE: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 68 Israel: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Israel: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 South Africa: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Latin America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Mexico: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Argentina: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Joint Pain Injections Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Joint Pain Injections Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Joint Pain Injections Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Joint Type
  • Figure 11. Global Joint Pain Injections Market, by Joint Type, 2022 & 2032 (USD Billion)
  • Figure 12. Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Joint Pain Injections Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!